Published in Cell Growth Differ on November 01, 1995
Farnesol-induced cell death and stimulation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase activity in tobacco cv bright yellow-2 cells. Plant Physiol (2000) 0.93
Tyrosine kinase-dependent modulation of 3-hydroxy-3-methylglutaryl-CoA reductase in human breast adenocarcinoma SKBR-3 cells. Biochem J (1998) 0.77
Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease. N Engl J Med (2009) 7.53
Epidemiological basis for clinical diagnosis of childhood malaria in endemic zone in West Africa. Lancet (1991) 5.11
Mutations in the gene encoding epsilon-sarcoglycan cause myoclonus-dystonia syndrome. Nat Genet (2001) 2.06
Purified donor NK-lymphocyte infusion to consolidate engraftment after haploidentical stem cell transplantation. Leukemia (2004) 1.97
Epidemiology and clinical features of vivax malaria imported to Europe: sentinel surveillance data from TropNetEurop. Malar J (2004) 1.90
Physical studies on ribonucleic acid polymerase from Escherichia coli B. Biochemistry (1970) 1.80
The influence of food on the pharmacokinetics of CGP 6140 (amocarzine) after oral administration of a 1200 mg single dose to patients with onchocerciasis. Br J Clin Pharmacol (1990) 1.76
Increased susceptibility to sporadic Parkinson's disease by a certain combined alpha-synuclein/apolipoprotein E genotype. Ann Neurol (1999) 1.74
Localized Darier disease. Implications for genetic studies. Arch Dermatol (1997) 1.65
GBA-associated PD presents with nonmotor characteristics. Neurology (2011) 1.63
Early natural course of transient encephalopathy after coronary artery bypass grafting. Crit Care Med (2000) 1.52
EFNS/MDS-ES/ENS [corrected] recommendations for the diagnosis of Parkinson's disease. Eur J Neurol (2013) 1.52
Parkin is transcriptionally regulated by ATF4: evidence for an interconnection between mitochondrial stress and ER stress. Cell Death Differ (2010) 1.52
High stem cell dose will not compensate for T cell depletion in allogeneic non-myeloablative stem cell transplantation. Bone Marrow Transplant (2002) 1.46
Differentiation between intracerebral hemorrhage and ischemic stroke by transcranial color-coded duplex-sonography. Stroke (1998) 1.45
Boost irradiation of breast carcinoma: teletherapy vs. brachytherapy. Eur J Obstet Gynecol Reprod Biol (2001) 1.40
Lrrk2 R1441C parkinsonism is clinically similar to sporadic Parkinson disease. Neurology (2008) 1.39
Direct primary closure without undermining in the repair of vermilionectomy defects of the lower lip. Br J Dermatol (2012) 1.38
Interleukin-10 gene knock-out mice: a model of chronic inflammation. Clin Immunol Immunopathol (1995) 1.34
Capsule expression by bovine isolates of Staphylococcus aureus from Argentina: genetic and epidemiologic analyses. J Clin Microbiol (2000) 1.27
Both farnesylated and geranylgeranylated RhoB inhibit malignant transformation and suppress human tumor growth in nude mice. J Biol Chem (2000) 1.27
HuR-dependent loading of miRNA RISC to the mRNA encoding the Ras-related small GTPase RhoB controls its translation during UV-induced apoptosis. Cell Death Differ (2011) 1.23
Zoledronic acid treatment impairs protein geranyl-geranylation for biological effects in prostatic cells. BMC Cancer (2006) 1.22
Differentiation of Parkinson's disease and atypical parkinsonian syndromes by transcranial ultrasound. J Neurol Neurosurg Psychiatry (2005) 1.16
Competitive inhibition of choline phosphotransferase by geranylgeraniol and farnesol inhibits phosphatidylcholine synthesis and induces apoptosis in human lung adenocarcinoma A549 cells. J Biol Chem (1998) 1.11
GGTI-298 induces G0-G1 block and apoptosis whereas FTI-277 causes G2-M enrichment in A549 cells. Cancer Res (1997) 1.11
RhoA prenylation is required for promotion of cell growth and transformation and cytoskeleton organization but not for induction of serum response element transcription. J Biol Chem (2000) 1.10
DI2ADEM: an adaptive hypermedia designed to improve access to relevant medical information. Proc AMIA Symp (2000) 1.07
Improving knowledge navigation with adaptive hypermedia. Med Inform Internet Med (2000) 1.07
Screening for mutations in synaptotagmin XI in Parkinson's disease. J Neural Transm Suppl (2004) 1.07
RhoB prenylation is driven by the three carboxyl-terminal amino acids of the protein: evidenced in vivo by an anti-farnesyl cysteine antibody. Proc Natl Acad Sci U S A (2000) 1.07
In vivo gene silencing in solid tumors by targeted electrically mediated siRNA delivery. Gene Ther (2007) 1.06
Concentrations of 2-methoxyoestrogens in human serum measured by a heterologous immunoassay with an 125I-labelled ligand. Acta Endocrinol (Copenh) (1983) 1.06
Incidence of Hajj-associated febrile cough episodes among French pilgrims: a prospective cohort study on the influence of statin use and risk factors. Clin Microbiol Infect (2009) 1.06
Cerebral activation patterns in patients with writer's cramp: a functional magnetic resonance imaging study. J Neurol (2001) 1.05
Ceruloplasmin gene variations and substantia nigra hyperechogenicity in Parkinson disease. Neurology (2004) 1.03
Prodromal features for Parkinson's disease--baseline data from the TREND study. Eur J Neurol (2014) 1.03
Periparotid lupus erythematosus panniculitis. Clinicopathologic correlation of two cases presenting as primary parotid disease. Arch Pathol Lab Med (1993) 1.02
In vivo restoration of RhoB expression leads to ovarian tumor regression. Cancer Gene Ther (2008) 1.02
Genotypic analysis of Staphylococcus aureus from milk of dairy cows with mastitis in Argentina. Epidemiol Infect (2001) 1.02
Acute effects of nitrogen dioxide after accidental release. Public Health Rep (1998) 1.02
Duty to recall. South Med J (1980) 1.01
Enhancement of antitumor immunity by expression of CD70 (CD27 ligand) or CD154 (CD40 ligand) costimulatory molecules in tumor cells. Cancer Gene Ther (1998) 0.99
Mutation analysis and association studies of the UCHL1 gene in German Parkinson's disease patients. Neuroreport (2000) 0.98
Novel ATP1A3 mutation in a sporadic RDP patient with minimal benefit from deep brain stimulation. Neurology (2008) 0.97
Importance of mevalonate-derived products in the control of HMG-CoA reductase activity and growth of human lung adenocarcinoma cell line A549. Int J Cancer (1993) 0.97
[Utilization of mosquitoes impregnated with deltamethrin in the battle against malaria]. Parassitologia (1984) 0.97
Biodistribution study of 99mTc-labeled LDL in B16-melanoma-bearing mice. Visualization of a preferential uptake by the tumor. Int J Cancer (1993) 0.97
Interleukin 10: an overview. Prog Growth Factor Res (1992) 0.97
Improvement of balance after audio-biofeedback. A 6-week intervention study in patients with progressive supranuclear palsy. Z Gerontol Geriatr (2010) 0.96
Inhibition of human tumor cell growth in vitro and in vivo by a specific inhibitor of human farnesyltransferase: BIM-46068. Int J Cancer (1999) 0.96
Genetic analysis of immunomodulating factors in sporadic Parkinson's disease. J Neural Transm (Vienna) (2000) 0.95
Microenvironment mesenchymal cells protect ovarian cancer cell lines from apoptosis by inhibiting XIAP inactivation. Cell Death Dis (2013) 0.95
Indium-111 labeling of low density lipoproteins with the DTPA-bis(stearylamide): evaluation as a potential radiopharmaceutical for tumor localization. Bioconjug Chem (1996) 0.93
Geranylgeranyl transferase inhibition stimulates anti-melanoma immune response through MHC Class I and costimulatory molecule expression. FASEB J (2005) 0.92
Tumoral calcinosis. Br J Surg (1972) 0.92
[Risk factors for human African trypanosomiasis in the Bipindi region of Cameroon]. Med Trop (Mars) (2001) 0.92
Bifonazole and clotrimazole. Their mode of action and the possible reason for the fungicidal behaviour of bifonazole. Arzneimittelforschung (1984) 0.92
Cross-sectional study discloses a positive family history for Parkinson's disease and male gender as epidemiological risk factors for substantia nigra hyperechogenicity. J Neural Transm (Vienna) (2007) 0.91
Selective inhibition of HER2 inhibits AKT signal transduction and prolongs disease-free survival in a micrometastasis model of ovarian carcinoma. Ann Oncol (2005) 0.90
Baroreflex sensitivity and power spectral analysis in different extrapyramidal syndromes. J Neural Transm (Vienna) (2008) 0.90
[Imported malaria at the Marseilles Hôpital-Nord, France: a prospective study on 352 cases between 2001 and 2003]. Med Mal Infect (2005) 0.90
Basal limbic system alteration in major depression: a hypothesis supported by transcranial sonography and MRI findings. Int J Neuropsychopharmacol (2001) 0.90
An integrated approach to distance learning with digital video in the French-speaking Virtual Medical University. Int J Med Inform (2007) 0.90
Neuroimaging in basal ganglia disorders: perspectives for transcranial ultrasound. Mov Disord (2001) 0.89
Tumor incidence in related hematopoietic stem cell donors. Bone Marrow Transplant (2010) 0.89
Psychopathological symptoms of depression in Parkinson's disease compared to major depression. Psychopathology (2003) 0.89
Low-density lipoprotein for delivery of an acrylophenone antineoplastic molecule into malignant cells. Cancer Res (1992) 0.88
The sepiapterin reductase gene region reveals association in the PARK3 locus: analysis of familial and sporadic Parkinson's disease in European populations. J Med Genet (2006) 0.88
Norepinephrine, active norepinephrine transporter, and norepinephrine-metabolism are involved in the generation of reactive oxygen species in human ovarian granulosa cells. Endocrinology (2012) 0.88
[Risk factors in prematurity and intrauterine growth retardation in Burkina Faso]. Rev Epidemiol Sante Publique (1995) 0.88
Adenovirus-mediated suicide gene transduction: feasibility in lens epithelium and in prevention of posterior capsule opacification in rabbits. Hum Gene Ther (1999) 0.88
Measurements of Cs absorption and retention in man. Health Phys (1989) 0.88
Radioresistance induced by the high molecular forms of the basic fibroblast growth factor is associated with an increased G2 delay and a hyperphosphorylation of p34CDC2 in HeLa cells. Cancer Res (1997) 0.87
Extended mutation analysis and association studies of Nurr1 (NR4A2) in Parkinson disease. Neurology (2004) 0.87
Proocytocin/neurophysin convertase from bovine neurohypophysis and corpus luteum secretory granules: complete purification, structure-function relationships, and competitive inhibitor. Biochemistry (1989) 0.87
Expression of type III hyperlipoproteinemia in patients homozygous for apolipoprotein E-2 is modulated by lipoprotein lipase and postprandial hyperinsulinemia. J Mol Med (Berl) (1998) 0.87
Sexually transmitted diseases and human immunodeficiency virus infection among women with genital infections in Burkina Faso. Int J STD AIDS (1995) 0.87
Etiologic study of genitourinary infections in women of childbearing age in Bobo-Dioulasso, Burkina Faso, 1992. Sex Transm Dis (1997) 0.87
Epidermal growth factor stimulates 3-hydroxy-3-methylglutaryl-coenzyme A reductase expression via the ErbB-2 pathway in human breast adenocarcinoma cells. Biochem Biophys Res Commun (1999) 0.87
Serum protein signature may improve detection of ductal carcinoma in situ of the breast. Oncogene (2009) 0.87
Management of severe hypokalemia in hospitalized patients: a study of quality of care based on computerized databases. Arch Intern Med (2001) 0.87
Reduction of immunosuppression for transplant-associated skin cancer: expert consensus survey. Br J Dermatol (2006) 0.86
Deciphering signaling pathways in clinical tissues for personalized medicine using protein microarrays. J Cell Physiol (2010) 0.86
Evidence for up-regulated low density lipoprotein receptor in human lung adenocarcinoma cell line A549. Biochimie (1993) 0.86